| Comparison of echocardiographic markers of right ventricular function in determining prognosis in chronic pulmonary disease MI Burgess, N Mogulkoc, RJ Bright-Thomas, P Bishop, JJ Egan, SG Ray Journal of the American Society of Echocardiography 15 (6), 633-639, 2002 | 318 | 2002 |
| Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation N Mogulkoc, MH Brutsche, PW Bishop, SM Greaves, AW Horrocks, ... American Journal of Respiratory and Critical Care Medicine 164 (1), 103-108, 2001 | 317 | 2001 |
| Intracardiac thrombus in Behçet's disease: a systematic review N Mogulkoc, MI Burgess, PW Bishop Chest 118 (2), 479-487, 2000 | 283 | 2000 |
| Acute Purulent Exacerbation of Chronic Obstructive Pulmonary Disease and Chlamydia pneumoniae Infection N Mogulkoc, S Karakurt, B Isalska, U Bayindir, T Celikel, V Korten, ... American journal of respiratory and critical care medicine 160 (1), 349-353, 1999 | 246 | 1999 |
| Pulmonary Langerhans’ cell histiocytosis: radiologic resolution following smoking cessation N Mogulkoc, A Veral, PW Bishop, U Bayindir, CAC Pickering, JJ Egan Chest 115 (5), 1452-1455, 1999 | 231 | 1999 |
| Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study SD Nathan, J Behr, HR Collard, V Cottin, MM Hoeper, FJ Martinez, ... The Lancet Respiratory Medicine 7 (9), 780-790, 2019 | 197 | 2019 |
| Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label … MM Hoeper, H Al-Hiti, RL Benza, SA Chang, PA Corris, JSR Gibbs, ... The Lancet Respiratory Medicine 9 (6), 573-584, 2021 | 121 | 2021 |
| Evaluation of CMV viral load using TaqMan™ CMV quantitative PCR and comparison with CMV Antigenemia in heart and lung transplant recipients M Guiver, AJ Fox, K Mutton, N Mogulkoc, J Egan Transplantation 71 (11), 1609-1615, 2001 | 119 | 2001 |
| Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised … J Behr, SD Nathan, WA Wuyts, NM Bishop, DE Bouros, K Antoniou, ... The Lancet Respiratory Medicine 9 (1), 85-95, 2021 | 105 | 2021 |
| Resequencing study confirms that host defense and cell senescence gene variants contribute to the risk of idiopathic pulmonary fibrosis C Moore, RZ Blumhagen, IV Yang, A Walts, J Powers, T Walker, M Bishop, ... American journal of respiratory and critical care medicine 200 (2), 199-208, 2019 | 105 | 2019 |
| The effect of inhaled corticosteroids on bronchoalveolar lavage cells and IL-8 levels in stable COPD patients D Ozol, T Aysan, ZA Solak, N Mogulkoc, A Veral, F Sebik Respiratory medicine 99 (12), 1494-1500, 2005 | 92 | 2005 |
| Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers? KA Johannson, I Strâmbu, C Ravaglia, JC Grutters, C Valenzuela, ... The Lancet Respiratory Medicine 5 (7), 591-598, 2017 | 89 | 2017 |
| Pulmonary 99mTc-DTPA aerosol clearance and survival in usual interstitial pneumonia (UIP) N Mogulkoc, MH Brutsche, PW Bishop, B Murby, MS Greaves, ... Thorax 56 (12), 916-923, 2001 | 70 | 2001 |
| The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis T Tran, M Šterclová, N Mogulkoc, K Lewandowska, V Müller, M Hájková, ... Respiratory research 21, 1-9, 2020 | 65 | 2020 |
| Apoptosis signals in atopy and asthma measured with cDNA arrays MH Brutsche, IC Brutsche, P Wood, A Brass, N Morrison, M Rattay, ... Clinical & Experimental Immunology 123 (2), 181-187, 2001 | 62 | 2001 |
| High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients S Ozkok, O Karakoyun-Celik, T Goksel, N Mogulkoc, D Yalman, G Gok, ... Lung cancer 62 (3), 326-333, 2008 | 57 | 2008 |
| High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer Y Anacak, N Mogulkoc, S Ozkok, T Goksel, A Haydaroglu, U Bayindir Lung cancer 34 (2), 253-259, 2001 | 51 | 2001 |
| Serial CT analysis in idiopathic pulmonary fibrosis: comparison of visual features that determine patient outcome J Jacob, L Aksman, N Mogulkoc, AJ Procter, B Gholipour, G Cross, ... Thorax 75 (8), 648-654, 2020 | 40 | 2020 |
| Lung cancer in patients with idiopathic pulmonary fibrosis: a retrospective multicentre study in Europe T Karampitsakos, P Spagnolo, N Mogulkoc, WA Wuyts, S Tomassetti, ... Respirology 28 (1), 56-65, 2023 | 39 | 2023 |
| Idiopathic pulmonary fibrosis is associated with common genetic variants and limited rare variants AL Peljto, RZ Blumhagen, AD Walts, J Cardwell, J Powers, TJ Corte, ... American journal of respiratory and critical care medicine 207 (9), 1194-1202, 2023 | 38 | 2023 |
